Mobile Product AuthenticationTM for Foundations and Donors »  

Foreign donors are rapidly becoming the most prominent bulk-purchase private sector clients for drug companies, and they currently have no easy way to track the impact of their donations. With Sproxil's solution, donors and development partners can see the uptake of their donated medicines, mosquito nets and other high-value items right from their work desks, as a chart or overlaid on a map in our online portal. This gives them additional assurance that they are not supporting corrupt government activities through the resale of their donations. Our MPATM technology also allows them to push governments for more transparency in the provisioning of healthcare services for the poor.

Sproxil Tackles the Great Balance »

Foundations are increasingly realising the need to optimize their funds over two key, and often opposing concerns: quality and access. Good quality comes at a price, and yet without great access, there is minimal impact. What good does an expired anti-malaria drug do in a society swamped by mosquitoes? Similarly, how does a $2/day community benefit from a $20/treatment anti-malaria drug? The impact of solving this challenge is huge: in addition to taking over a million lives annually,

"malaria costs Africa $12 billion in lost GDP every year and consumes 40% of all public health spending."1

The WHO estimates that as many as 200,000 of those lost lives could be saved if all anti-malarials were genuine, and of good quality.
The Great Balance
Fortunately, Sproxil's MPATM technology brings the world closer to a solution to this great challenge. Our service provides automatic protection against counterfeits, helping patients avoid suspicious products that may have a significantly negative effect on their lives. MPATM also has the ability to interface with prominent drug access campaings, like the Medicines Transparency Alliance (MeTA), a DFID-funded initiative to help reduce the cost of medication by providing consumers with suggested drug retail prices, based on the cost at the manufacturing plant. MeTA has had initial success showing that when the information asymetry is erased, patients can lobby and negotiate with their politicians and local health professionals for more accessible healthcare pricing.
Sproxil Solves both Quality and Access

Solving the Drug Adherence Problem »

As a pervasively connected, always-on personal communications device, mobile phones are a fabulous means of delivering personalized alerts in real time. Even when taking genuine drugs, patients often forget how often to take their medication. Such mistakes could have very unfortunate consequences, such as boosting parasitic resistance due to sub-potenet drug dosage.

The effects of poor drug dosage administration could be as severe as outright counterfeiting. Counterfeiters are increasingly adding minute amounts of the real drug ingredients, so malaria parasites are "vaccinated" against real drugs, making them ineffective and short-lived, affecting the incentives for pharma companies to keep developing new drugs.

To solve these two problems with a single shot, donors can sponsor text messages reminding patients when they should be taking their drugs. This helps solve the drug adherence problem and the drug quality problem, since MPATM provides automatic protection against counterfeits.

Request a brochure today »

See how our Mobile Product AuthenticationTM technology can boost regulatory efficiency, protect consumers from fakes and enhance your product's brand loyalty. Click here


[1] Medicines for Malaria Venture (MMV) Brochure, 2008  ↑ top




Sproxil and its affiliates have been featured by:

Awards
Sproxil CEO awarded a Clinton Global Initiative Outstanding Commitment Award.  Sproxil wins IBM SmartCamp Boston, gains support from IBM & partners Sproxil wins support from USAID and Western Union via the African Diaspora Marketplace initiative.  Sproxil recognized in Mobile Infrastructure category and with    Sproxil CEO awarded a 2009 IEEE GOLD Humanitarian Award. Sproxil CEO supported by Pat Tillman Foundation.  Sproxil Technology powers Forum Nokia Calling All Innovators EMEA first prize award.  Sproxil selected as an inaugural NCIIA Venture Well Cohort member.   EAPD awards Sproxil for innovation.
Media & Features
Featured in WSJ online and print editions in articles `Start-Up Helps Fight Fake Drugs in Nigeria??? and `Awash in Fake Drugs, Nigeria Fights Back???.  Sproxil featured on Reuters showing in-depth Entrepreneur???s Edge video and exclusive CEO Entrepreneurs Journal. Featured on Discovery News Analysis article.  Sproxil CEO Blogs on Chamber Post & speaks on panel with leading scholars on fake drugs at US Chamber of Commerce. Featured on PRI???s The World Podcast. Featured on CNN Money/Fortune Small Business as one of six ideas to change the world. Highlighted on silicon valley venture capital technology blog VentureBeat. Sproxil CEO featured on Partnership for Safe Meds `Nigeria Using SMS To Thwart Counterfeit Drugs???. Sproxil CEO featured on BBC Health Check.
© 2008 - 2012 Sproxil, Inc. All rights reserved. team@sproxil.com | Terms of Service